Secretagogues derived from oxalobacter formigenes
AssigneeOxthera Intellectual Property AB
InventorsElisabeth LINDNER, Helena COWLEY, Aaron COWLEY, Maria ÅKERMAN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
Claims16
1-13. (canceled)
A pharmaceutical product comprising:
- (i) an isolated secretagogue derived from Oxalobacter formigenes, and
- (ii) oxalate-degrading Oxalobacter formigenes bacteria.
A method for reducing oxalate in a subject in need thereof, comprising administering to said subject (i) an isolated secretagogue derived from Oxalobacter formigenes, and (ii) oxalate-degrading Oxalobacter formigenes bacteria, wherein the method is effective to reduce urinary and/or plasma oxalate in the subject.
Dependencies are inferred from the claim text.